FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to a composition containing a basic surfactant, tocol phosphate, water, an active agent and optionally an oil, wherein active agent and/or optional oil is contained in hydrophobic phase.
EFFECT: what is offered is a pharmaceutical composition.
7 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PROPOFOL DELIVERY SYSTEMS | 2016 |
|
RU2709812C2 |
| SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
| OIL-IN-WATER OPHTHALMIC EMULSIONS CONTAINING PROSTAGLANDINS | 2008 |
|
RU2460516C2 |
| SELF-EMULSING DRUG DELIVERY SYSTEMS (SEDDS) FOR OPHTHALMIC MEDICINE DELIVERY | 2016 |
|
RU2746083C2 |
| TRANSDERMAL PLASTER | 2011 |
|
RU2553350C2 |
| CICLOSPORIN ANALOG MICROEMULSION PRECONCENTRATE | 2002 |
|
RU2317067C2 |
| CYCLOSPORIN-CONTAINING AND PRACTICALLY OIL-FREE COMPOSITIONS | 2000 |
|
RU2249461C2 |
| CARRIER COMPOSITION | 2010 |
|
RU2577233C2 |
| MICROEMULSION COMPOSITIONS INCLUDING SUBSTANCE P ANTAGONISTS | 2005 |
|
RU2397759C2 |
| MICROEMULSION COMPOSITIONS | 2019 |
|
RU2787998C1 |
